In pre-clinical testing, we were able to deliver the biologic of Avastin on a prolonged, sustained basis. We plan to continue our Tethadur pre-clinical research, seeking to provided sustained delivery of biologics for opthalmic and systemic treatment. In the first quarter of FY17, we have taken significant steps to improve our Product Research and Development. We are delighted to welcome Dr. Dario Paggiarino, our new Chief Medical Officer. He is responsible for supervising our research and development programs. no dataBringing us the benefit of his over 25 years of experience in the pharmaceutical industry, Dario has gotten quickly up to speed, and is already deeply involved in our various programs. We also completed the consolidation of our research and development into our US facility in Watertown, Massachusetts closing our facility in Malvern, the UK. We believe this consolidation will facilitate research and product development in both our Tethadur and Durasert programs, with the additional benefit of reducing operating overhead. Turning to Iluvien for diabetic macular edema, and that’s a product that we license to Alimera Sciences, we were pleased to see our licensee, Alimera, reported higher sales in its 2016 second quarter.

For the original version including any supplementary images or video, visit

Standardization of uveitis nomenclature for reporting clinical data. There he was involved in research in radiation biology and received the husking Scholarship. homoeopathic remedies have not been studied scientifically for uveitis. Links to other sites are provided for information only — they do not constitute endorsements of those other sites. © 1997- 2013 A.D.A.M., Inc. Long-term steroid use may produce side effects such as stomach ulcers, osteoporosis bone thinning, diabetes, cataracts, glaucoma, cardiovascular disease, weight gain, fluid retention, and bushing’s syndrome. no dataTry retain MD About half of all uveitis cases — with most occurring in the anterior urea — don’t have an obvious cause. Symptoms of uveitis can vary depending on the location of the inflammation. AMA Ophthalmology. shied Dr., MD, face, face Dr. A recent NEI-funded study, called the Multicenter Uveitis Treatment Trial MUST, compared the safety and effectiveness of conventional treatment for these forms of uveitis, which suppresses a patient’s entire immune system, with a new local treatment that exclusively suppressed inflammation in the affected eye. With treatment, most people with uveitis will improve within days or weeks. The dark hole in the middle of the iris is the pupil. Rare cases are chronic and require close, long term monitoring. Thiagarajan G, Chandani S, Harinarayana Mao S, et al.

Leave a Reply

Your email address will not be published. Required fields are marked *